California K-12 Schools Now Eligible for neffyinSchools Program, Offering Needle-Free Epinephrine at No Cost for Emergency Use

Core Insights - California has joined 23 other states in the neffyinSchools program, allowing schools to receive free neffy® (epinephrine nasal spray) for emergency use [1][2][3] - The neffyinSchools program aims to provide schools with the necessary tools to respond quickly to severe allergic emergencies, particularly anaphylaxis, which can occur rapidly and without prior diagnosis [2][3] - Since its launch in January 2025, the program has expanded to over 8,000 schools across 24 states, with plans for further expansion as legislation evolves [2][4] Company Overview - ARS Pharmaceuticals, Inc. is a biopharmaceutical company focused on empowering at-risk patients and caregivers to manage allergic reactions that could lead to anaphylaxis [1][15] - The company is commercializing neffy®, a nasal spray indicated for emergency treatment of Type I allergic reactions, including anaphylaxis, in patients aged 4 years and older who weigh at least 33 lbs. [15][6] - neffy is recognized as the first significant innovation in epinephrine delivery for allergic reactions in over 35 years, addressing limitations of traditional auto-injectors [2][14] Program Details - The neffyinSchools program provides eligible public and private K-12 schools with two cartons (four single-use doses) of neffy at no cost for emergency situations [3][5] - Schools can apply online to receive the product, which includes both 1 mg and 2 mg doses of neffy, depending on the weight of the children [5][3] - To date, ARS Pharma has donated nearly 45,000 doses of neffy to participating schools, which can also receive replacements upon use or expiration [3][4] Market Context - Approximately 40 million people in the U.S. experience Type I allergic reactions, with a significant number diagnosed and treated for severe reactions that may lead to anaphylaxis [14] - Despite the availability of epinephrine auto-injectors, many patients and caregivers delay or do not administer treatment during emergencies due to various limitations [14] - The neffyinSchools program aims to mitigate these issues by providing a more accessible and user-friendly option for emergency treatment in schools [2][3]